Bora Pharmaceuticals and GSK are renewing a five-year manufacturing partnership with the signing of a new strategic agreement.

In question is a facility in Mississauga, Ontario, which Bora agreed to acquire from GSK in March 2020. The two parties finalized the transaction in December of that year.

Bora Recently Updated Manufacturing Site

As recently as July 2025, Bora shared an update on the facility. This was when the company installed a filling line, from Norden Machinery, to expand its production capabilities.

Not only that, Bora said at the time, but it also enabled larger volumes at higher speeds with greater flexibility. This, according to the company, has particular relevance for dermatologic products.

GSK remains the largest pharmaceutical partner that operates at the Mississauga facility. There, Bora provides end-to-end manufacturing services for more than 20 commercial product lines, and in excess of 335 individual products. Indications covered by these products include HIV, malaria, pneumonia, parasitic infections, depression, migraine, acne, eczema, and psoriasis.

In the more than five years since the Mississauga site joined the Bora network, it has supported 32 total clients. More than 60 products advanced in that time, with more than 400 project and development batches completed.

Under the renewed collaboration, the partnership is expanding to allow GSK access to multiple Bora sites. Chief among these is the new Bora oral solid dosage site in Maple Grove, Minn.

Officials Weigh In on GSK Partnership

Bobby Sheng, Chairman of Bora Group and CEO of Bora, said trust and a commitment to quality define GSK’s partnership.

“Committing through 2030 speaks to our shared focus on value and reliability,” Sheng said.

J.D. Mowery, President of Bora’s CDMO division, agreed.

“Strong partnerships like this are foundational to the continued growth of Bora’s CDMO business,” Mowery said.

Meanwhile, John Lawrie, VP of Operations in Mississauga, said Bora is ready to continue to support GSK medicine manufacturing.

“Our teams, systems, and processes are ready to deliver on time, in full, consistently,” Lawrie said.